2016 Media Coverage Archives

2016 Media Coverage Archives

November 30, 2016

WCTD 2016 (World Congress on Clinical Trials in Diabetes)

Mr. James Nolan, CEO of the contract research organization InClinica (Wayne, PA), highlighted seven key challenges for enrollment in modern clinical trials from an industry perspective. [more]

Close Concerns

November 30, 2016

InClinica CEO Speaks To World Congress On Clinical Trials In Diabetes

James Nolan, CEO of InClinica, Inc. ‒ a global, clinical CRO ‒ will present two lectures to the World Congress on Clinical Trials in Diabetes on Wednesday, November 30 in Berlin. [more]

BioSpace

November 15, 2016

Diabesity Highlighted

Diabetes expert and researcher Professor Paul Zimmet AO delivered a talk on Diabetes In The Asia Pacific Region: Current and Future Trends, at the International Medical University. The talk highlighted the prevalence of Diabesity (obesity and type 2 diabetes) in Asia particularly in China, India, Singapore and Malaysia where economic progression and prosperity coupled with an overindulgence in rich, fatty foods and a sedentary lifestyle has resulted in an alarming increase in type 2 diabetes among the young.

The New Straits Times

November 7, 2016

InClinica expands global operations with exec hires in the U.S. and Europe

Velocity Fund Partners clearly has big plans for its newly acquired and relaunched CRO InClinica. Since the acquisition was announced in August, InClinica has been in a restless hiring mood, appointing three regional VPs of business development in the U.S. and Europe. [more]

FierceBioTech

October 18, 2016

US-based, PE-backed InClinica sets up Asia Pacific headquarter in KL

US-based clinical contract research organization (CRO) InClinica has opened a new regional head-office in Kuala Lumpur in a bid to expand its global network of clinical research in Asia Pacific. [more]

Deal Street Asia

August 18, 2016

InClinica Expands European Presence

InClinica, a global, clinical CRO, announced that Dr. Thomas Morris, has been appointed Medical Director of InClinica Ltd., representing the company’s European operations. [more]

BioSpace

August 4, 2016

Velocity Fund launches InClinica from acquired CRO IndiPharm

Pittsburgh’s Velocity Fund Partners has picked up CRO IndiPharm for an undisclosed amount, renaming the Philadelphia firm InClinica. [more]

FierceBioTech

August 3, 2016

Former Highmark CEO’s private equity fund makes acquisition

The private equity fund launched earlier in 2016 by former Highmark Inc. CEO Kenneth Melani has acquired a company. [more]

Pittsburgh Business Times

August 3, 2016

Valley Forge CRO gets new owner, new name

Velocity Fund Partners, a Pittsburgh private equity company, has acquired Valley Forge, Pennsylvania-based clinical contract research organization Indipharm and is relaunching the CRO as InClinica. [more]

Philadelphia Business Journal